The panelist discusses how vitiligo’s psychological and social impacts significantly affect patients’ quality of life and treatment adherence, necessitating a holistic approach that addresses both ...
While IL-23 inhibitors, which include guselkumab, tildrakizumab, and risankizumab, are currently FDA-approved solely for the treatment of psoriasis, several other inflammatory skin conditions have ...
A new dual wavelength phototherapy unit has been launched at RML Hospital in New Delhi to provide effective and cost-free treatment for psoriasis patients, amidst worsening symptoms during winter ...